Neurontin is approved by the US Food and Drug Administration to treat the following disorders:
  • Partial seizures with or without secondary generalization (adjunctive)
  • Postherpetic neuralgia

In addition it is commonly used 'off-label' (which means that it is not formally approved by the US FDA but has shown good anecdotal efficacy in treating the disorder) for the following disorders;
  • Neuropathic pain/chronic pain
  • Anxiety Disorders